JEWEL DAVIS: Open Payments
NPI 1487382826 · ERWIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 58 payments from 14 companies in 2025. Trend: 2023 $743 · 2024 $1,197 · 2025 $1,351
Food & beverage: $1,351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $295 |
| Novo Nordisk Inc | 7 | $203 |
| ABBVIE INC. | 17 | $181 |
| Axsome Therapeutics, Inc. | 4 | $167 |
| KYOWA KIRIN, INC. | 1 | $140 |
| Gilead Sciences, Inc. | 1 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Exact Sciences Corporation | 4 | $74 |
| Viatris Specialty LLC | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: AIRSUPRA, Ozempic, Auvelity, VRAYLAR, Epclusa, CAPLYTA, WAINUA, QULIPTA.
Industry payments across TN — which companies pay providers there.
